Noom GLP-1 Rx Plus Program GLP-1 treatment paired with Noom behavior change Program 2 Includes medication (if prescribed), ongoing care, and full program access
Unlike GLP-1 at the time, which would get chewed up rapidly by enzymes in the human body, exendin-4 caused blood glucose to drop to a normal leveland stay there for hours, or even days
[61, 62, 63, 64, 65] Based on World Health Organization (WHO), worldwide adult obesity has more than doubled since 1990, while adolescent obesity has quadrupled
BMI 27 with weight-related conditions, such as: Type 2 diabetes or prediabetes Hypertension High cholesterol Sleep apnea Fatty liver disease (NAFLD) PCOS Insulin resistance Patients in this range may be candidates because GLP-1 medications act on pathways related to blood sugar, appetite, and metabolic regulation